NFE2L2 and neurodegenerative disease: We are looking at the use of histone deacetylase inhibitors (HDACis) in combination with DNA demethylating compounds to reactivate the expression of Nrf2 and other antioxidant response genes that may be silenced in neurodegenerative diseases.